Blog

Advances in cancer care must consider the impact on patients’ reproductive health – ASCO

Photo taken from ASCO/LinkedIn

Sep 13, 2024, 19:19

Advances in cancer care must consider the impact on patients’ reproductive health – ASCO

ASCO – American Society of Clinical Oncology made the following post on LinkedIn:

“Advances in cancer care must consider the impact on patients’ reproductive health. Join the FDA and ASCO for a free virtual workshop, October 1 and October 8, exploring this vital topic.

Event details:

Title: Measuring Toxicity in Reproductive Organs During Oncology Drug Development: An FDA – ASCO 2 Day Virtual Workshop
Date: Tuesday, October 1, 2024 & Tuesday, October 8, 2024
Time: 1:00 pm – 5:00 pm EST (October 1) / 9:00 am – 12:15 pm EST (October 8)

Source: ASCO/LinkedIn

American Society of Clinical Oncology ASCO cancer cancer care Cancer Impact cancer treatment FDA October events OncoDaily Oncology oncology research patient care patient support reproductive health virtual workshop

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage